Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (488) Arrow Down
Filter Results: (488) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (655)
    • People  (2)
    • News  (81)
    • Research  (488)
    • Events  (1)
  • Faculty Publications  (317)

Show Results For

  • All HBS Web  (655)
    • People  (2)
    • News  (81)
    • Research  (488)
    • Events  (1)
  • Faculty Publications  (317)
← Page 9 of 488 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • August 2003
  • Teaching Note

Pharmacyclics: Financing Research and Development (TN)

By: Malcolm P. Baker and Richard S. Ruback
Teaching Note for (9-201-056). View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry
Citation
Purchase
Related
Baker, Malcolm P., and Richard S. Ruback. "Pharmacyclics: Financing Research and Development (TN)." Harvard Business School Teaching Note 204-012, August 2003.
  • September 1986
  • Case

BOC Group: Ohmeda (A)

The president of Ohmeda, a wholly owned company of the BOC Group, plans to grow the company's medical equipment sales from $95 million in 1985 to $158 million in five years by focusing on the sale of "high-tech" equipment. At the same time, the president expects to... View Details
Keywords: Marketing Communications; Salesforce Management; Marketing Channels; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Moriarty, Rowland T., Jr. "BOC Group: Ohmeda (A)." Harvard Business School Case 587-080, September 1986.
  • September 2016
  • Article

Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing

By: Katy E. French, Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel and Thomas Feeley
Background: With the movement towards bundled payments, stakeholders should know the true cost of the care they deliver. Time-driven activity-based costing (TDABC) can be used to estimate costs for each episode of care. In this analysis, TDABC is used to both... View Details
Keywords: Cost; Insurance; Health Care and Treatment; Insurance Industry; Insurance Industry
Citation
Find at Harvard
Purchase
Related
French, Katy E., Alexis B. Guzman, Augustin C. Rubio, John C. Frenzel, and Thomas Feeley. "Value Based Care and Bundled Payments: Anesthesia Care Costs for Outpatient Oncology Surgery Using Time-driven Activity-based Costing." Healthcare: The Journal of Delivery Science and Innovation 4, no. 3 (September 2016): 173–180.
  • 10 Jan 2005
  • Research & Ideas

Motivation and the Cross-Sector Alliance

government blames the industrial sector, thus holding manufacturers responsible. The upcoming period of legislative meetings will tackle the new law on containers and packages. There are several proposals,... View Details
Keywords: by James Austin, Ezequiel Reficco & SEKN research team
  • January 2014 (Revised December 2014)
  • Case

GenapSys: Business Models for the Genome

By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble

GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details

Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation & Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Citation
Educators
Purchase
Related
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
  • 21 Jun 2010
  • Research & Ideas

Strategy and Execution for Emerging Markets

challenge is to understand local customer needs and produce localized products. In our book we discuss companies including GE, which has been innovating in the medical sector, View Details
Keywords: by Martha Lagace
  • October 2024
  • Case

Allurion: Competing in the Age of GLP-1

By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso
Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details
Keywords: Corporate Entrepreneurship; Health Care and Treatment; Global Strategy; Competitive Strategy; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States; United Kingdom; France; India; Brazil; Middle East
Citation
Educators
Related
Tadikonda, Satish, Rajiv Lal, David Lane, and Sarah Sasso. "Allurion: Competing in the Age of GLP-1." Harvard Business School Case 525-011, October 2024.
  • March 2000 (Revised May 2003)
  • Teaching Note

Owens & Minor, Inc. (A) and (B) TN

By: V.G. Narayanan and Lisa Brem
Teaching Note for (9-100-055) and (9-100-079). View Details
Keywords: Medical Devices and Supplies Industry; Medical Devices and Supplies Industry
Citation
Purchase
Related
Narayanan, V.G., and Lisa Brem. "Owens & Minor, Inc. (A) and (B) TN." Harvard Business School Teaching Note 100-100, March 2000. (Revised May 2003.)
  • April 2013
  • Case

Southfield Packaging

By: Michael Beer and Alisa Zalosh
Southfield Packaging provides packaging materials and services to medical device manufacturers. The case examines the relationship between a corporate vice president, Mark Sanders, and one of his direct reports, Regional Manager Frank Belby. Sanders' preparation for... View Details
Keywords: Rank and Position; Performance Evaluation; Problems and Challenges; Management Teams; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Beer, Michael, and Alisa Zalosh. "Southfield Packaging." Harvard Business School Brief Case 913-562, April 2013.
  • Research Summary

Overview

Navid has worked with different organizations across various industries, from the Federal Reserve to medical device manufacturers, heavy construction equipment sellers, and B2B software providers, to assemble proprietary datasets in studying organizational buying.... View Details

  • November 2021 (Revised December 2024)
  • Case

Kermit PPI

By: Kyle Myers, Matt Grennan and Sarah Mehta
Launched in 2011, Kermit PPI helped hospitals save money on expensive orthopedic implants and devices by enabling them to renegotiate their contracts with device manufacturers and better monitor compliance. In 2021, as they look to grow, they are entertaining two... View Details
Keywords: Health; Health Care and Treatment; Strategy; Expansion; Information Technology; Applications and Software; Supply Chain; Supply Chain Management; Contracts; Health Industry; Health Industry; Health Industry; United States; Maryland
Citation
Educators
Purchase
Related
Myers, Kyle, Matt Grennan, and Sarah Mehta. "Kermit PPI." Harvard Business School Case 622-007, November 2021. (Revised December 2024.)
  • February 2002 (Revised August 2002)
  • Case

Inhale Therapeutics: Executing and Growing the Business Model

Inhale is about to bring a novel technology to market that uses inhalation to administer drugs that formerly required injection. Inhale must now decide which way to evolve its business model. This will determine the future direction of growth for the company. View Details
Keywords: Business Model; Technological Innovation; Health Care and Treatment; Growth and Development Strategy; Medical Devices and Supplies Industry
Citation
Find at Harvard
Related
Chesbrough, Henry W., and Gillian Morris. "Inhale Therapeutics: Executing and Growing the Business Model." Harvard Business School Case 602-132, February 2002. (Revised August 2002.)
  • 25 Sep 2018
  • First Look

New Research and Ideas, September 25, 2018

from Medical Device Recalls By: Ball, George P., Jeffrey T. Macher, and Ariel Dora Stern Abstract—When innovations are successfully commercialized into new products, they can... View Details
Keywords: Dina Gerdeman
  • 31 Aug 2021
  • Book

Feeling Powerless at Work? Time to Agitate, Innovate, and Orchestrate

and children by not only providing medical care, but also working to rehabilitate people’s homes and provide vocational training for parents. She initially shied away from... View Details
Keywords: by Jay Fitzgerald
  • September 2012 (Revised September 2012)
  • Course Overview Note

Building Life Science Businesses Fall 2012: Course Outline and Syllabus

By: Richard G. Hamermesh and Richard G. Hamermesh
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Citation
Related
Hamermesh, Richard G. "Building Life Science Businesses Fall 2012: Course Outline and Syllabus." Harvard Business School Course Overview Note 812-167, September 2012. (Revised from original June 2012 version.)
  • March 2013
  • Teaching Plan

Corruption at Siemens (TP) (A), (B), (C) and (D)

By: Paul Healy
This teaching plan is designed to be used in conjunction with the case Corruption at Siemens (A), HBS No. 108033 [and its related B and C cases] to help faculty deepen students' comprehension of business issues and to energize classroom discussion. View Details
Keywords: Corruption; Management; Medical Devices and Supplies Industry; Germany
Citation
Purchase
Related
Healy, Paul. "Corruption at Siemens (TP) (A), (B), (C) and (D)." Harvard Business School Teaching Plan 113-092, March 2013.
  • April 2004 (Revised June 2004)
  • Case

Entrepreneurship Goes Global: ResMed's Gamble

By: Christopher A. Bartlett, Andrew N. McLean and Meg Glinska
On the basis of its innovative medical device for treating sleep apnea, CEO Peter Farrell has made Australian-born ResMed a successful global company. But the company is struggling to implement a strategy to expand the device from its focused core market to a much... View Details
Keywords: Business Model; Globalization; Innovation and Management; Management; Marketing Channels; Production; Expansion; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Bartlett, Christopher A., Andrew N. McLean, and Meg Glinska. "Entrepreneurship Goes Global: ResMed's Gamble." Harvard Business School Case 304-051, April 2004. (Revised June 2004.)
  • 23 Oct 2018
  • First Look

New Research and Ideas, October 23, 2018

labor between innovative new entrants and industry incumbents, endowed with complementary assets, is common in many industries. Such settings are distinct because new entrants have the additional option to... View Details
Keywords: Dina Gerdeman
  • August 2013
  • Course Overview Note

Building Life Science Businesses Fall 2013: Course Outline and Syllabus

By: Richard G. Hamermesh
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses. View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Citation
Purchase
Related
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
  • February 2020
  • Teaching Note

Theranos: Who Has Blood on Their Hands? (A) and (B)

By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091. View Details
Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Lawsuits and Litigation; Medical Devices and Supplies Industry; California; United States
Citation
Purchase
Related
Hsieh, Nien-he, and Christina R. Wing. "Theranos: Who Has Blood on Their Hands? (A) and (B)." Harvard Business School Teaching Note 620-102, February 2020.
  • ←
  • 9
  • 10
  • …
  • 24
  • 25
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.